Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Koch

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 15, 2021
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021Thomas Harder, Wiebe Külper-Schiek, Sarah Reda, et al.
Vaccine|April 26, 2016
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in GermanyHannah Christensen, Tom Irving, Judith Koch, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2021
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
The Lancet Regional Health. Europe|September 24, 2021
Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)Nicole Friedrich, Christina Poethko-Müller, Ronny Kuhnert, et al.
Vaccine|February 25, 2014
Cost-effectiveness of childhood rotavirus vaccination in GermanyPamela Aidelsburger, Kristin Grabein, Katharina Böhm, et al.
The Pediatric Infectious Disease Journal|January 22, 2013
Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011Cornelia Adlhoch, Marina Hoehne, Martina Littmann, et al.
Human Vaccines & Immunotherapeutics|October 5, 2013
Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011Anja Takla, Merle M Böhmer, Christina Klinc, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2016
Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014Judith Koch, Wiebke Hellenbrand, Susanne Schink, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 22, 2015
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal diseaseWiebke Hellenbrand, Judith Koch, Thomas Harder, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 22, 2024
Needs and feasibility of living systematic reviews (LSRs): Experience from LSRs on COVID-19 vaccine effectivenessWiebe Külper-Schiek, Iris Thielemann, Antonia Pilic, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 15, 2021
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021Thomas Harder, Wiebe Külper-Schiek, Sarah Reda, et al.
Vaccine|April 26, 2016
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in GermanyHannah Christensen, Tom Irving, Judith Koch, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2021
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
The Lancet Regional Health. Europe|September 24, 2021
Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)Nicole Friedrich, Christina Poethko-Müller, Ronny Kuhnert, et al.
Vaccine|February 25, 2014
Cost-effectiveness of childhood rotavirus vaccination in GermanyPamela Aidelsburger, Kristin Grabein, Katharina Böhm, et al.
The Pediatric Infectious Disease Journal|January 22, 2013
Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011Cornelia Adlhoch, Marina Hoehne, Martina Littmann, et al.
Human Vaccines & Immunotherapeutics|October 5, 2013
Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011Anja Takla, Merle M Böhmer, Christina Klinc, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 16, 2016
Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014Judith Koch, Wiebke Hellenbrand, Susanne Schink, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 22, 2015
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal diseaseWiebke Hellenbrand, Judith Koch, Thomas Harder, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 22, 2024
Needs and feasibility of living systematic reviews (LSRs): Experience from LSRs on COVID-19 vaccine effectivenessWiebe Külper-Schiek, Iris Thielemann, Antonia Pilic, et al.
Pageof 5